AC
CLX icon

Armistice Capital’s Clorox CLX Stock Holding History

Armistice Capital’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,923
Closed -$2.09M – 394
2025
Q3 		$2.09M Buy
+16,923
New +$2.1M 0.03% 149
2024
Q4 		– Sell
-2,295
Closed -$374K – 248
2024
Q3 		$374K Sell
2,295
-2,243
-49% -$332K 0.01% 199
2024
Q2 		$619K Buy
+4,538
New +$630K 0.01% 173
2023
Q1 		– Sell
-173,000
Closed -$24.3M – 234
2022
Q4 		$24.3M Buy
+173,000
New +$24.6M 0.42% 46
2021
Q4 		– Sell
-124,000
Closed -$20.5M – 153
2021
Q3 		$20.5M Sell
124,000
-154,000
-55% -$26.5M 0.35% 70
2021
Q2 		$50M Buy
278,000
+28,000
+11% +$5.11M 0.9% 29
2021
Q1 		$48.2M Buy
250,000
+190,000
+317% +$36.6M 1.11% 28
2020
Q4 		$12.1M Buy
+60,000
New +$12.4M 0.41% 60

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Armistice Capital's CLX Position: Q4 2025 in Review

Armistice Capital sold out of Clorox (CLX) in Q4 2025, closing a stake of 16,923 shares — an estimated $2.09M sold.

Armistice Capital first reported a position in CLX in Q4 2020 and held it in 8 quarters. The position peaked at $50M in Q2 2021. 1,052 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Armistice Capital reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Armistice Capital sold 16,923 Clorox shares in Q4 2025, an estimated $2.09M.
  • Armistice Capital first reported a position in Clorox in Q4 2020 and held it in 8 quarters.
  • Armistice Capital's Clorox position peaked at $50M in Q2 2021.
  • 1,052 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.